ibandronic acid has been researched along with Carcinoma 256, Walker in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauss, F; Hayes, WC; Kim, SZ; Kurth, AA; Müller, R; Shea, M | 1 |
| Bauss, F; Hovy, L; Kim, SZ; Kurth, AH; Sedlmeyer, I | 1 |
| Bauss, F; Juraschek, M; Krempien, B; Seibel, MJ; Woitge, HW | 1 |
3 other study(ies) available for ibandronic acid and Carcinoma 256, Walker
| Article | Year |
|---|---|
Preventative ibandronate treatment has the most beneficial effect on the microstructure of bone in experimental tumor osteolysis.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Carcinoma 256, Walker; Diphosphonates; Disease Models, Animal; Female; Femur; Ibandronic Acid; Image Processing, Computer-Assisted; Rats | 2007 |
Treatment with ibandronate preserves bone in experimental tumour-induced bone loss.
Topics: Animals; Bone Resorption; Carcinoma 256, Walker; Diphosphonates; Ibandronic Acid; Rats; Rats, Sprague-Dawley | 2000 |
Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis.
Topics: Animals; Biomarkers; Carcinoma 256, Walker; Diphosphonates; Female; Ibandronic Acid; Longitudinal Studies; Models, Biological; Osteolysis; Parathyroid Hormone-Related Protein; Proteins; Rats; Rats, Wistar | 2000 |